Navigation Links
Indegene Introduces TrialPedia 2.0 with 'Advantage Insights', Making It the Most Comprehensive Clinical Trial Analytics and Decision Support Platform for the Pharma Industry

ISELIN, New Jersey, August 20, 2012 /PRNewswire/ --

Indegene Inc. (, a leading global pharmaceutical and healthcare solutions provider, today announced the launch of TrialPedia 2.0 with Advantage Insights for clinical trial analytics and decision support.


The number of drugs approved by the USFDA over the years has been declining, and is testament to the difficulties pharmaceutical companies continue to face to drive revenues. As companies grapple with shrinking pipelines, stricter safety and regulatory requirements, and spiraling costs to bring products to the marketplace, the need for clinical trial analytics is paramount.

TrialPedia 2.0, a proprietary platform offered by Indegene, helps Clinical Development and Operations, R&D, Competitive Intelligence (CI), BD & Licensing, as well as Strategic Marketing professionals effectively analyze clinical literature and trial data seamlessly, and benchmark competitive Clinical Development Programs (CDPs) across the industry. TrialPedia provides quick and comprehensive answers to strategic clinical development and marketing questions including market evolution, competitive label claims, licensing options, and future sales projections. It includes industry leading features such as therapy area specific query parameters, claim space prediction tools, trial feasibility, operations analysis, and identification of competitive differentiators. TrialPedia 2.0 combines over 300 man-years of effort in assimilating knowledge to build a comprehensive solution.

Clients can further enhance the value of TrialPedia via Advantage Insights - a service bureau that is designed to enhance the business value of clinical trial analytics and help clients comprehensively research, study, monitor, report, and derive insights from the global clinical trial landscape. In this model, Indegene leverages TrialPedia and its expertise to perform analysis and reporting on behalf of the client. Clients can also avail of custom research and analysis through bundled Analyst Hours Support.

Manish Gupta, CEO - Indegene said "With Advantage Insights, in addition to clients gaining access to TrialPedia 2.0, they can leverage our deep research and analytics expertise for all their reporting and analysis needs. We believe that this will enable clients to navigate the business environment more effectively and with greater responsiveness."

About Indegene

Indegene is a leading provider of R&D, commercial and marketing solutions to global pharmaceutical and healthcare organizations. We partner with clients to drive both productivity and revenues by delivering better patient outcomes, optimizing cost, enhancing R&D agility, and improving sales and marketing effectiveness. We apply deep scientific knowledge, flexible delivery models, proprietary technology, and a client-centric approach to drive transformational initiatives. To learn more about Indegene, visit us at

For further information contact:

US and Europe
Ann Marie Craggan
Indegene Inc.
Phone: +1-732-750-2901

Sherin Varghese
Genesis Burson-Marsteller
Mobile: +91-99161-15584

SOURCE Indegene Lifesystems Pvt Ltd
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. IRIDEX Introduces Non-Invasive MicroPulse™ Therapy for Glaucoma
2. Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in Gastroenterology Portfolio
3. Richard Wolf Medical Instruments introduces groundbreaking 5514 Endocam Performance HD
4. Rochester Medical Introduces Magic3® Coude Tip Hydrophilic Intermittent Catheter
5. Velos, Inc. Introduces Mobile App for Oncology Adverse Events and Graft-Versus-Host Disease at 2012 ASCO Annual Meeting
6. IDEV Technologies Introduces SurePath™ Guidewires
7. ConvaTec Introduces Enhanced Flexi-Seal® SIGNAL® FMS
8. HealthONE® Introduces the Colorado Center for Robotic Surgery(SM)
9. PeriGen, Inc. Introduces New, Advanced Perinatal System at National Perinatal Nursing Convention
10. PharmaNet/i3 Introduces PharmaNet/i3 Strategic Resourcing
11. Zimmer Introduces First Porous Metal Interbody Implant for Lumbar Spine in the United States
Post Your Comments:
(Date:11/24/2015)... NEW DELHI , November 25, 2015 ... fear invoked due to repeated failure of IVF cycles. ... Rani Bhatia was totally dejected and had lost all hopes that ... the first Indian miracle child conceived after failure of ... to abroad (UK) before they decided to take one last ...
(Date:11/24/2015)... 2015  Array BioPharma Inc. (Nasdaq: ARRY ... Ron Squarer , will present at the ... The public is welcome to participate in the ... website.Event:Piper Jaffray Annual Healthcare ConferencePresenter:  , Ron Squarer, ... p.m. Eastern Time Webcast: , ...
(Date:11/24/2015)... , 24. November 2015 Avery ... Pacemaker Systems, ist erfreut, die Berufung von ... bekannt geben zu können. ... --> Foto - ... (Schweden). Von 1984-1986 war er Fellow des ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... Smiles by Stevens is pleased ... moderate facial wrinkling. While many patients are aware of the benefits of Botox® in ... delivers to those suffering with discomfort, soreness, and pain as a result of Jaw ...
(Date:11/25/2015)... ... ... Beddit® has launched a new Android app for use with ... more intuitive SleepScore™ that rates sleep quality on a 100-point scale and makes it ... a proprietary algorithm. Beddit analyzes the data to provide an easy to understand scientific ...
(Date:11/25/2015)... Livonia, MI (PRWEB) , ... November 25, 2015 , ... ... at Presence Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the ... the medical and surgical intensive care units (totaling 30 beds) from May 2014 through ...
(Date:11/25/2015)... , ... November 25, 2015 , ... Today, Mothers ... our nation’s roadways has dropped below 10,000 for the first time since 2011. In ... 2013. , According to data released by the National Highway Traffic Safety Administration (NHTSA), ...
(Date:11/25/2015)... Md (PRWEB) , ... November 25, 2015 , ... ... Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for ... of this disease. The Periwinkle Pioneers, nominated by the public, will receive special ...
Breaking Medicine News(10 mins):